Lyft and Continuum Partner for Transportation Solutions
Chicago, IL – Today, Lyft and Continuum Clinical announced a partnership that will help to provide transportation solutions for patients who are enrolled in pharmaceutical clinical trials.
This partnership represents the first of its kind among pharmaceutical vendors who work on behalf of pharmaceutical companies to recruit patients for clinical trials.
“We’re thrilled to partner with Lyft to offer patients enrolled in clinical trials a new level of convenience,” said Nariman Nasser, vice president of site optimization at Continuum Clinical. “We believe that this service will make enrolling and staying in a study easier, especially for those patients with limited resources and access to transportation.”
Lack of transportation is frequently cited as a barrier to retaining patients in clinical trials. Through Continuum’s partnership with Lyft, patients enrolled in clinical trials will be able to use the Lyft app to secure transportation to and from the trial site, free of charge.
The program will help to ensure that patients enrolled in the trials won’t miss appointments, which may potentially disqualify them from the trial. Continuum plans on trialing the Lyft program this quarter for a national study on lupus.
“Through our partnership with Continuum Clinical, we’re able to provide patients with safe, affordable and reliable rides,” said Gyre Renwick, head of enterprise healthcare partnerships at Lyft. “We look forward to working with Continuum to help the community get around more efficiently.”
In 2016, Lyft partnered with a number of senior care providers and healthcare systems for non-emergency transportation services. Continuum Clinical will be a preferred provider for clinical trial transportation solutions.
For over 20 years, Continuum Clinical has worked with eight of the top ten pharmaceutical companies around the world to recruit patients for clinical trials through integrated marketing efforts. They have recruited patients for more than 600 studies in over 75 disease states. Currently, Continuum is working with over 1,900 active study sites throughout the U.S.
About Continuum Clinical
Continuum Clinical is a global healthcare research and communications company. With over thirty years of experience, Continuum Clinical brings together a unique blend of world-class experience in key disciplines, including observational research, marketing, communications, site optimization health economics, and outcomes research. We excel in providing seamless resources for pharmaceutical and biotech products - from patient recruitment and retention for clinical trials to late stage studies and health economics and outcomes research. Continuum Clinical provides a unique blend of resources and perspectives, proven expertise, and innovative solutions throughout the entire continuum of a product’s lifecycle - from pre-launch into the real world. Headquartered in the US, Continuum Clinical has employees in Europe and expanded worldwide network of resources. www.continuumclinical.com.
About Lyft
Lyft was founded in June 2012 by Logan Green and John Zimmer to improve people's lives with the world's best transportation. Lyft is the fastest growing rideshare company in the U.S and is available in more than 200 cities. Lyft is preferred by drivers and passengers for its safe and friendly experience, and its commitment to effecting positive change for the future of our cities. For more information on Lyft for Healthcare, visit http://get.lyft.com/healthcare/
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
